ArticleFuture oncology (London, England)2025

Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer.

Ritu Salani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.